|1.||Zhu, Zhengmao: 1 article (07/2013)|
|2.||Hao, Jianlei: 1 article (07/2013)|
|3.||Zhang, Song: 1 article (07/2013)|
|4.||Zhao, Liqing: 1 article (07/2013)|
|5.||Sun, Huayan: 1 article (07/2013)|
|6.||Wei, Jun: 1 article (07/2013)|
|7.||Xia, Siyuan: 1 article (07/2013)|
|8.||Wang, Puyue: 1 article (07/2013)|
|9.||Chen, Xi: 1 article (07/2013)|
|10.||Yin, Zhinan: 1 article (07/2013)|
|1.||Sarcoma (Soft Tissue Sarcoma)
11/01/1959 - "Chromosomal studies on primary methyl-cholanthrene-induced sarcomas in the mouse."
04/01/1980 - "The effect of pretreatment with glucan on the development of an inoculated syngeneic methyl cholanthrene induced sarcoma was studied. "
04/01/1977 - "By immunizing BALF/c (H-2d) mice against normal tissues from C57BL/6J (H-2d), C3Hf (H-2k) and DBA/2 (H-2d), but not from AKR (H-2k) strains, resistance was induced to the subsequent challenge of the 'syngeneic' methyl-cholanthrene-induced BALB/c sarcoma ST5; lymph node cells from alloimmune BALB/c mice were also able to exert a parallel cytotoxic effect against in vitro cultured ST5 cells. "
01/01/1960 - "The chromosomal constitution of methyl-cholanthrene induced sarcomas and their variants induced and tested in isogenic resistant strains."
01/01/1951 - "The cheek pouch of the hamster as a site for the transplantation of a methyl-cholanthrene-induced sarcoma."
06/01/1990 - "The two types of transplantable methyl cholanthrene induced fibrosarcoma in rats was used to find out the possible relationship between the fibrinolytic, procoagulant activities and the metastasizing capacity of the tumours. "
01/15/1979 - "Fibrosarcoma induced by administration of methyl cholanthrene into post extraction sockets of mandibular molars in rats."
03/01/1976 - "Effect of normal syngeneic lymphoid cells on growth of methyl cholanthrene induced fibrosarcomas in mice."
07/01/2013 - "In this study, by using IL-27p28 conditional knockout mice, we demonstrate that IL-27 is critical in protective immune response against methyl-cholanthrene-induced fibrosarcoma and transplanted B16 melanoma, and dendritic cells (DCs) are the primary source. "
04/01/1984 - "The tumours included two methyl-cholanthrene-induced fibrosarcomas (D7, D8), a metastatic variant of D8 (D8M) and a spontaneous adenocarcinoma (ST-2). "
12/01/1988 - "At comparable doses, (+/-)cholanthrene-trans-9,10-diol was approximately 50% as potent as cholanthrene as a tumor initiator whereas the diol-epoxide was only minimally active. "
12/01/1988 - "Cholanthrene was a moderate tumor-initiator with maximal tumor yields of 6.90 and 8.86 tumors per mouse at 200 and 600 nmol doses, respectively, after 20 weeks of promotion. "
03/01/1976 - "Effect of syngeneic sensitized lymphoid cells on incidence and growth of methyl cholanthrene-induced and spontaneous tumors in mice."
06/25/1973 - "[Early changes of the endometrium and histogenesis of malignant tumors in the corpus uteri of the mouse after implantation of 20-methyl cholanthrene (I)]."
01/01/1973 - "[The action of gestagen on the endometrium and tumor development in the corpus uteri of the mouse after implantation of 20-methyl cholanthrene (II) (author's transl)]."
11/15/1985 - "A syngeneic tumor system in DBA/2 mice consisting of a methyl-cholanthrene-induced, weakly metastatic lymphoma, L5178YE (= Eb), its spontaneous strongly metastatic variant, L5178YES (= ESb), and an unrelated, methylcholanthrene-induced, metastasizing tumor, MDAY-D2, were used to study the relationship between metastatic behavior and composition of GSLs. "
|4.||4-anisyltetrazolium blue (ATB)
|2.||Transplantation (Transplant Recipients)